By Rodrigues, H.S.; Monteiro, M.T.T.; Torres, D.F.M.
As the development of a dengue vaccine is ongoing, we simulate an hypothetical vaccine as an extra protection to the population. In a rst phase, the vaccination process is studied as a new compartment in the model, and di erent ways of distributing the vaccines investigated: pediatric and random mass vaccines, with distinct levels of e cacy and durability. In a second step, the vaccination is seen as a control variable in the epidemiological process. In both cases, epidemic and endemic scenarios are included in order to analyze distinct outbreak realities